Kristen, A., Ajroud-Driss, S., Conceição, I., Gorevic, P., Kyriakides, T., & Obici, L. (2018). Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegenerative disease management, 9(1), . https://doi.org/10.2217/nmt-2018-0033
Chicago-Zitierstil (17. Ausg.)Kristen, Arnt, Senda Ajroud-Driss, Isabel Conceição, Peter Gorevic, Theodoros Kyriakides, und Laura Obici. "Patisiran, an RNAi Therapeutic for the Treatment of Hereditary Transthyretin-mediated Amyloidosis." Neurodegenerative Disease Management 9, no. 1 (2018). https://doi.org/10.2217/nmt-2018-0033.
MLA-Zitierstil (9. Ausg.)Kristen, Arnt, et al. "Patisiran, an RNAi Therapeutic for the Treatment of Hereditary Transthyretin-mediated Amyloidosis." Neurodegenerative Disease Management, vol. 9, no. 1, 2018, https://doi.org/10.2217/nmt-2018-0033.